Cargando…
Repositioning Drugs to the Mitochondrial Fusion Protein 2 by Three-Tunnel Deep Neural Network for Alzheimer's Disease
Alzheimer's disease (AD) is a common neurodegenerative dementia in the elderly. Although there is no effective drug to treat AD, proteins associated with AD have been discovered in related studies. One of the proteins is mitochondrial fusion protein 2 (Mfn2), and its regulation presumably be re...
Autores principales: | Wang, Xun, Zhong, Yue, Ding, Mao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917248/ https://www.ncbi.nlm.nih.gov/pubmed/33659028 http://dx.doi.org/10.3389/fgene.2021.638330 |
Ejemplares similares
-
Drug repositioning for esophageal squamous cell carcinoma
por: Bennett, Adam N., et al.
Publicado: (2022) -
Prediction of Drug-Likeness Using Deep Autoencoder Neural Networks
por: Hu, Qiwan, et al.
Publicado: (2018) -
A drug repositioning algorithm based on a deep autoencoder and adaptive fusion
por: Chen, Peng, et al.
Publicado: (2021) -
An Integrated System Biology Approach Yields Drug Repositioning Candidates for the Treatment of Heart Failure
por: Yang, Guodong, et al.
Publicado: (2019) -
StarGazer: A Hybrid Intelligence Platform for Drug Target Prioritization and Digital Drug Repositioning Using Streamlit
por: Lee, Chiyun, et al.
Publicado: (2022)